Tag: U.S
U.S. Participates in WHO-led Flu Vaccine Meeting
The United States is actively participating in a crucial meeting led by the World Health Organization (WHO) to decide on the flu viruses that will be included in next winter's influenza vaccines, despite the...
Limited Opportunities for U.S. Scientists Amid Policy Changes
In today's ever-evolving scientific landscape, the Trump administration's recent policy changes have sparked concerns among U.S. scientists about their future opportunities. As restrictions on research studies and funding loom large, many academics are left...
WHO-led Flu Vaccine Meeting: Will U.S. Attend?
In a few weeks, a pivotal meeting of influenza experts from across the globe is set to take place at the Crick Worldwide Influenza Center in London. Led by the World Health Organization (WHO),...
Threat of Brain Drain Undermining U.S. Biomedicine Dominance
The U.S. Biomedicine Dominance in Peril: Threat of Brain Drain LoomsA sense of unease and uncertainty grips the scientific community as they grapple with the repercussions of the tumultuous policies set forth by the...
Concerns Rise Over Integrity of Key Genetic Databases amid U.S. Science Shake-Up
Amidst the changing landscape of U.S. science under the Trump administration, concerns are mounting over the integrity of key genetic databases that scientists worldwide rely on daily for research. The National Library of Medicine,...
NIH’s Indirect Cost Rate Cut Threatens US Research Infrastructure
A Critical Blow to American Research: NIH's Decision to Cut Indirect Costs Threatens Scientific InnovationIn a groundbreaking move that could have far-reaching implications for American scientific progress, the National Institutes of Health (NIH) has...
Prominent RFK Jr. Stands Firm Against Threatening Pharmaceutical Patents for Lower Drug Prices
Robert F. Kennedy Jr., former President Trump’s nominee for the position of Health and Human Services Secretary, made his stance clear during his Senate Finance Committee confirmation hearing in Washington. The discussion revolved around...
Key Cancer Drug by AstraZeneca and Daiichi Sankyo Gets First U.S. Approval
Key Cancer Drug by AstraZeneca and Daiichi Sankyo Receives First U.S. ApprovalIn a groundbreaking development in the fight against breast cancer, a cutting-edge chemotherapy treatment developed by AstraZeneca and Daiichi Sankyo has been granted...
Newsom’s Unfinished Health Care Project: The Impact of Trump – KFF Health News
California's Health Care Future at Risk Amid Political TurmoilIn a state as vast as California, health care remains a pressing issue, with Governor Gavin Newsom at the helm of ambitious reform efforts. However, with...
